Also, while direct mutational activation of the PI3K pathway in many breast tumors will preclude therapy based solely on caloric restriction [157], a number of reports have identified metabolic sensitivities associated with activation of specific oncogenic signaling pathways. The gene discussed is PIK3CA; the disease is breast neoplasm.